Navigation Links
10-Week "Biotech Entrepreneur Educational Program" Enrolling in New York City
Date:12/11/2012

NEW YORK, Dec. 11, 2012 /PRNewswire/ -- Kauffman FastTrac® in conjunction with Propero/Healthcare Accelerator (Propero/HCA) announces the launch of FastTrac® LifeSciences™, a 10-week professional business course designed specifically for aspiring entrepreneurs who either have an idea for a science business or have already started a business and need a plan to successfully grow.

Instructed by Laurence "Larry" Chaityn, founder of Propero/HCA and Global Head Healthcare Investment Banking at Kaminski Partners, the FastTrac LifeSciences course will provide participants a forum to:

  • Test their business' product/service, patient base, financial plan and technological viability
  • Find the target market for their business and discover its competitive advantage
  • Learn how to value their business and raise money from funding sources
  • Determine the stages to profitability
  • Learn successful regulatory strategies, including correct protocol, achievable endpoints and correct patient participants
  • Understand reimbursement strategies including differing reimbursement environments, multiple codes, limited reimbursement and attended monitoring

FastTrac LifeSciences will be held at Loeb & Loeb, 345 Park Avenue, 21st floor Conference Center. Classes begin Monday, January 28, 2013 at 5:30 p.m. EST and will be held each successive Monday for 10 weeks.  Space is limited. Participants can register at http://properohca.affiliate.fasttrac.org/.

"Interesting science and a novel mechanism of action are important when launching a biotechnology company, but success hinges on a multitude of factors, many of which occur in the boardroom and not at the bench," Chaityn said. "I look forward to helping life sciences entrepreneurs develop the essential business strategies that will allow them to navigate the hurdles of today's regulatory and financial landscape."

About Laurence Chaityn:
Laurence "Larry" Chaityn is the founder of Propero/HCA and Managing Director and Global Head Healthcare Investment Banking at Kaminski Partners.  With more than 12 years of healthcare and life science consulting experience, he has built expertise in deal sourcing, deal review, due diligence investigation and client facing operations. Chaityn has worked with executive and senior management at Johnson & Johnson, Pfizer, Bayer Pharmaceuticals, Merck, Bristol Meyers Squibb (BMS) and others.

About Propero/Healthcare Accelerator:
ProperoHCA's mandate is to grow Healthcare/Life Science companies. One of the key assets is the network of nationwide hospital CEOs, CFOs & CAOs. This relationship, coupled with our knowledge of the healthcare landscape enables us to map specific hospital challenges and business initiatives for our clients. The overarching goal is to create a scalable sales organization that minimizes the cost of customer acquisition, streamlines the overall sales cycle and maximizes the revenue yield per employee.

Media Contact:
Tiberend Strategic Advisors, Inc.
Claire Sojda
212-827-0020
csojda@tiberend.com


'/>"/>
SOURCE Kauffman FastTrac
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
2. Minority Biomedical Entrepreneurship Conference
3. Entrepreneurs to Eat Problems for Breakfast in San Diego
4. Leading Technology Incubator Honors Extraordinary Entrepreneurs
5. invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
6. Western Carolina University, College of Business Appoints New Director of Entrepreneurship and Innovation
7. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
8. Hawaii Tech Asia Takes Hawaii & US Entrepreneurs To China
9. Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Detroit As Part Of Educational Initiative
10. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
11. NIRI San Diego May Meeting: Seasoned IROs Discuss "Tips & Tactics for Establishing and Maintaining A Successful Investor Relations Program"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
Breaking Biology News(10 mins):